Ethan Chow Background: Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disease currently affecting an estimated 11.9 million people worldwide, and is projected to exceed 25.2 million by 2050. 1 PD is classically described as neuronal degeneration and alpha-synuclein aggregation in the dopaminergic neurons of the substantia nigra pars…

Adithya Shastri Background: Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. It currently affects over 6 million Americans and is a leading cause of disability in older adults13. Diagnosis often occurs late, after significant neuronal damage, which limits the effectiveness…

Caitlin Sannes Background: Intimate partner violence (IPV) is defined as abuse or aggression that occurs in a romantic relationship and includes physical violence, sexual violence, stalking, and emotional abuse and manipulation1. It is currently estimated that one third of women will experience some degree of IPV in their lifetime and…

Alayne Morrel Background:  It has been noted in several psychiatric studies that there is an absence of reported patients with schizophrenia who had comorbid blindness.¹⁻⁶  This spurred multiple studies ranging from surveying state hospitals to studies encompassing entire populations, such as Australia and Denmark.⁴ ⁷ ⁸ If a correlation exists,…

Andres G. Morales-Martinez Background:  Phantom limb pain (PLP) affects up to 64% of amputees and is characterized by painful sensations in the absent limb 1,2. Conventional treatments, including pharmacologic approaches and non-pharmacologic methods like transcutaneous electrical nerve stimulation (TENS) and mirror therapy, often provide inconsistent and short-lived relief without targeting…